Anesthesia | Jotup

GE Health Executive Joins U.S. Anesthesia Partners

Retrieved on:

Jeudi, mai 9, 2024

Medical Supplies, Medical Devices, Health, Surgery, General Health, Pharmaceutical, Education, USAP, Anesthesia, Innovation, Patient, Physician, AI, Nursing

U.S. Anesthesia Partners (“USAP”), a leading provider of high-quality anesthesia care, today announced that Jeff Terry has joined the national practice as Executive Vice President of Health System Strategy and Innovation.

Key Points:

U.S. Anesthesia Partners (“USAP”), a leading provider of high-quality anesthesia care, today announced that Jeff Terry has joined the national practice as Executive Vice President of Health System Strategy and Innovation.
He was most recently at General Electric Healthcare, where he was the Founding CEO of the GE Clinical Command Center.
“I’m thrilled to be working with the outstanding clinicians at USAP and the health systems we serve to continue setting the standard in anesthesia care,” said Terry.
“I’ve been impressed with USAP’s physician-led model, and the opportunity that it creates for USAP to help health systems and clinicians achieve success in a constantly evolving health care environment.

From Crisis to Control: Revamp Anesthesia Locum Staffing to Supercharge Margins, Says Surgical Directions

Retrieved on:

Mercredi, mai 8, 2024

Anesthesiology, Anesthesia, MD, Hospital

It also forces hospitals to rethink surgeon access and surgical volume as anesthesia costs outpace the financial viability of surgical services.

Key Points:

It also forces hospitals to rethink surgeon access and surgical volume as anesthesia costs outpace the financial viability of surgical services.
"The cost of anesthesiology is threatening margins in the procedural care space," says Jason Klopotowski, MD, Surgical Direction's lead physician managing director.
Leveraging Technology: Utilize predictive analytics tools such as Merlin™ to optimize patient throughput, anesthesia staffing, and surgeon access.
Improved Caseload Management: Conduct daily reviews to streamline staffing based on actual case volume, preventing unnecessary locum use and optimizing resource utilization.

Phoenix-Micron Announces New Animal Stand with Integrated Anesthesia Delivery

Retrieved on:

Vendredi, mai 3, 2024

Frustration, Isoflurane, Mask, Inhalation, IACUC, Mouse, Injection, Research, Anesthesia, Biomaterial, Eye, Anesthetic, ARVO, Rat, Telescopic sight

BEND, Ore., May 3, 2024 /PRNewswire-PRWeb/ -- Phoenix-Micron, Inc. ("Phoenix"), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, today announced the MICRON Animal Stand - Pro. For the first time, inhalation anesthetic delivery is integrated into an animal stand specifically designed for ophthalmic imaging. The new, patent-pending, design is plumbed for anesthesia delivery and venting, includes the WhiskerWipes™ animal mask, and supports integrated animal heating.

Key Points:

For the first time, inhalation anesthetic delivery is integrated into an animal stand specifically designed for ophthalmic imaging.
The new, patent-pending, design is plumbed for anesthesia delivery and venting, includes the WhiskerWipes™ animal mask, and supports integrated animal heating.
It snaps in place on the animal platform to connect with integrated inhalation anesthesia delivery and venting, enabling sustained animal sedation.
Today, we are excited to bring integrated anesthesia delivery and animal heating to our micro-adjustable animal stand product line to improve preclinical ophthalmic imaging where inhalation anesthetics are used."

AANA President Appointed to VA's National Research Advisory Council

Retrieved on:

Mardi, avril 30, 2024

Congress, DNP, FAAN, Systematic review, Veterans' affairs, Doctor of Philosophy, Research, Anesthesia, Military reserve force, Veteran, Cochrane US Network, Certified Registered Nurse Anesthetist, Multimedia, Translation, Health, Nursing

ROSEMONT, Ill., April 30, 2024 /PRNewswire/ -- (AANA) —Dru Riddle, PhD, DNP, CRNA, FAAN, president of the American Association of Nurse Anesthesiology (AANA), has been appointed to the Department of Veterans Affairs' (VA) National Research Advisory Council by the Secretary of the VA, Denis McDonough.

Key Points:

ROSEMONT, Ill., April 30, 2024 /PRNewswire/ -- (AANA) —Dru Riddle, PhD, DNP, CRNA, FAAN, president of the American Association of Nurse Anesthesiology (AANA), has been appointed to the Department of Veterans Affairs' (VA) National Research Advisory Council by the Secretary of the VA, Denis McDonough.
"I'm honored to be chosen to serve on the council and assist the VA with a national research program that is focused on providing quality healthcare to our veterans," said Riddle.
The National Research Advisory Council advises the VA secretary on all matters related to its research and development program.
Riddle's term on the VA National Research Advisory Council concludes on March 31, 2026.

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024

Retrieved on:

Vendredi, mai 3, 2024

Relaxation, Safety, Growth, EUR, Life, Tax, Anesthesia, Lithium

Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first quarter of 2024 thanks to good overall demand.

Key Points:

Lübeck – Drägerwerk AG & Co. KGaA increased its order intake in the first quarter of 2024 thanks to good overall demand.
Net of currency effects, net sales fell by 2.6 percent to around EUR 735.8 million (3 months 2023: EUR 761.1 million).
Earnings before interest and taxes (EBIT) amounted to EUR 15.1 million (3 months 2023: EUR 29.1 million).
This shows that demand for our Technology for Life remains high,” says Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG.

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

Retrieved on:

Jeudi, avril 18, 2024

Pain, FDA, Hospital, Food, Health Canada, Depression, Quality, Suicidal ideation, Ketamine, Anesthesia, Mental health, Symantec Endpoint Protection, DSM-IV codes, CRL, Anxiety, Letter, Pharmaceutical industry

Ketamine has been on the FDA’s drug shortage list since February 2018, which is believed to have encouraged the widespread availability of compounded ketamine products not FDA approved for psychiatric disorders.

Key Points:

Ketamine has been on the FDA’s drug shortage list since February 2018, which is believed to have encouraged the widespread availability of compounded ketamine products not FDA approved for psychiatric disorders.
Ketamine is an essential medicine used for anesthesia and analgesia (pain relief) listed on the WHO Essential Medicines List .
In Canada, ketamine has been classified as a Tier 3 drug shortage since February 2023, and Health Canada has approved ketamine for use as a sedative and painkiller in hospital settings.
A recently published new peer-reviewed study on the real-world effectiveness of ketamine intravenous therapy demonstrated significant patient improvement for depression, anxiety and suicidal ideation.

AACOM Recognizes Award-Winning Leaders and Students at Annual Conference

Retrieved on:

Mercredi, avril 17, 2024

AACOM, Learning, School, Research, Health, COSGP, ACOM, Science, Anesthesia, Medicine, Osteopathy, Student, Philosophy, Nursing

Bethesda, MD, April 17, 2024 (GLOBE NEWSWIRE) -- Today, the American Association of Colleges of Osteopathic Medicine (AACOM) is proud to honor four outstanding individuals during its sold-out annual conference, Educating Leaders 2024.

Key Points:

Bethesda, MD, April 17, 2024 (GLOBE NEWSWIRE) -- Today, the American Association of Colleges of Osteopathic Medicine (AACOM) is proud to honor four outstanding individuals during its sold-out annual conference, Educating Leaders 2024.
“AACOM is honored to recognize Dr. Getz’s inspiring career and accomplishments and these student doctors’ early display of passion and success.”
The Robert A. Kistner Award is presented each year on behalf of the AACOM Board of Deans.
Individuals who receive this award are nominated and selected in recognition of their significant contributions to osteopathic medical education throughout their careers.
“I am humbled, especially knowing the incredible efforts of fellow students around the world working to address healthcare disparities.

PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine

Retrieved on:

Mardi, avril 16, 2024

Pain, FDA, Hospital, Food, Health Canada, Depression, Quality, Suicidal ideation, Ketamine, Anesthesia, Mental health, Symantec Endpoint Protection, DSM-IV codes, Anxiety, Pharmaceutical industry

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application (“ANDA”) for Ketamine that was accepted by the U.S. Food and Drug Administration (the “FDA”) and assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA”) goal date of April 29, 2024.

Key Points:

TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application (“ANDA”) for Ketamine that was accepted by the U.S. Food and Drug Administration (the “FDA”) and assigned a Generic Drug User Fee Amendments of 2022 (“GDUFA”) goal date of April 29, 2024.
The Company is prepared to address potential FDA requests and concerns immediately and will update shareholders as they occur.
Ketamine has been on the FDA’s drug shortage list since February 2018, which is believed to have encouraged the widespread availability of compounded ketamine products not FDA approved for psychiatric disorders.
A recently published new peer-reviewed study on the real-world effectiveness of ketamine intravenous therapy demonstrated significant patient improvement for depression, anxiety and suicidal ideation.

Global Airway Management Devices Market Analysis and Forecast, 2023-2033: Competitive Landscape, Ecosystem, Reimbursement Scenario, Patent Analysis, Partnerships, Collaborations, & Business Expansions - ResearchAndMarkets.com

Retrieved on:

Lundi, avril 29, 2024

General Health, Health, Medical Devices, Chronic obstructive pulmonary disease, Airway management, Competitive landscape, Catheter, Anesthesia, Asthma, Growth, Prevalence, COPD, Airline

North America is poised to emerge as a major contributor to the growth of the airway management devices market.

Key Points:

North America is poised to emerge as a major contributor to the growth of the airway management devices market.
What are the major market drivers, challenges and opportunities in the global airway management devices market and their case studies?
What is the market share of the leading segments and sub-segments of the global airway management devices market?
How will each segment of the global airway management devices market grow during the forecast period?

Global Dermal Fillers Industry Research 2023-2035: Market Set to Expand; Hyaluronic Acid Dominates with Innovation in Minimally Invasive Aesthetics - ResearchAndMarkets.com

Retrieved on:

Vendredi, avril 12, 2024

Dermal fillers are a type of injectable treatment which consists of hyaluronic acid in the form of a gel-like substance, also known as facial fillers.

Key Points:

Dermal fillers are a type of injectable treatment which consists of hyaluronic acid in the form of a gel-like substance, also known as facial fillers.
Dermal fillers often comprise hyaluronic acid, lactic acid, calcium hydroxyapatite, polymethyl methacrylates and polyacrylamide gels.
Of these, 86% of the procedures were done using hyaluronic fillers, with rest accounting for non hyaluronic acid fillers.
The dermal fillers market report presents an in-depth analysis of the various companies that are engaged in the global dermal fillers industry, across different segments, as defined below: